{"member_organisations": "", "identification_number": "946394317378-56", "fields_of_interest": "Foreign and Security Policy and Defence, Research and innovation, External Relations, Public Health, Borders and Security", "head_office_address": "1455, Pennsylvania Avenue, N.W. The Willard, Suite 1225", "full_time_equivalent_fte": "1,75", "person_with_legal_responsibility": "Chris Frech", "financial_year_start_date": "01/01/2017", "grants": "", "country_code": "US", "head_office_country": "United States", "eu_initiatives": "Emergent develops specialised products and medical countermeasures for healthcare professionals and governments to protect nations against CBRN threats.  \n \nAreas of EU focus: Public health, cross-border health threats, security, medicinal products for human use, internal security, crisis management, counter-terrorism, EU CBRN Action Plan.", "level_of_interest": "European, global, national", "organisation_name": "Emergent BioSolutions", "belgium_office_post_code": "", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": -77.0327842, "source": "", "belgium_office_address": "", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "subsection": "Companies & groups", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "275000", "registration_date": "15/05/2015", "website_address": "http://emergentbiosolutions.com/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Washington D.C.", "membership": "", "head_office_post_code": "20004", "goals__remit": "As a global specialty pharmaceutical company, Emergent offers specialised products to healthcare providers and governments to address medical needs and emerging health threats.", "industry_forums": "", "inter_groups": "", "number_of_persons_involved": "7", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "lat": 38.8968979, "estimate_of_costs_as_a_range": "", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Inc.", "person_in_charge_of_eu_relations": "Chris Frech", "customers": "", "belgium_office_post_box": "", "position": "Senior Vice President Government Affairs", "belgium_office_city": "", "head_office_phone": "(+1)2406313398"}